Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:diselenide
go back to main search page
Accession:CHEBI:47026 term browser browse the term
Definition:Compounds having the structure RSe2R, with R =/= H.
Synonyms:related_synonym: diselenides



show annotations for term's descendants           Sort by:
selenocystine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression ISO selenocystine results in increased expression of BAX protein CTD PMID:35863474 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO selenocystine results in decreased expression of BCL2 protein CTD PMID:35863474 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression
ISO 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [selenocystine results in decreased expression of CASP3 protein] CTD PMID:35863474 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp8 caspase 8 decreases expression ISO selenocystine results in decreased expression of CASP8 protein CTD PMID:35863474 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Casp9 caspase 9 decreases expression ISO selenocystine results in decreased expression of CASP9 protein CTD PMID:35863474 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Cat catalase decreases expression ISO selenocystine results in decreased expression of CAT protein CTD PMID:35863474 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Dclre1c DNA cross-link repair 1C decreases expression ISO selenocystine results in decreased expression of DCLRE1C protein CTD PMID:39461470 NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions
increases expression
ISO NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of GCLC mRNA] CTD PMID:22807314 NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
JBrowse link
G H2ax H2A.X variant histone increases phosphorylation
multiple interactions
increases expression
ISO selenocystine results in increased phosphorylation of H2AX protein
[selenocystine co-treated with Cisplatin] results in increased expression of H2AX protein; Cisplatin promotes the reaction [selenocystine results in increased expression of H2AX protein]; selenocystine promotes the reaction [Cisplatin results in increased expression of H2AX protein]
CTD PMID:35863474 PMID:39461470 NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
Ensembl chr 4:44,671,786...44,673,239
JBrowse link
G Lig4 DNA ligase 4 decreases expression ISO selenocystine results in decreased expression of LIG4 protein CTD PMID:39461470 NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO selenocystine inhibits the reaction [Methylmercury Compounds results in decreased activity of MAPK1 protein] CTD PMID:23838314 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO selenocystine inhibits the reaction [Methylmercury Compounds results in decreased activity of MAPK3 protein] CTD PMID:23838314 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression
multiple interactions
ISO selenocystine results in decreased expression of MKI67 protein
Cisplatin promotes the reaction [selenocystine results in decreased expression of MKI67 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of MKI67 protein]
CTD PMID:39461470 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
affects localization
ISO NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of TXNRD1 mRNA]
selenocystine affects the localization of NFE2L2 protein
CTD PMID:22807314 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
affects expression
increases expression
ISO NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of NQO1 mRNA]
selenocystine affects the expression of NQO1 mRNA
selenocystine results in increased expression of NQO1 protein
CTD PMID:22807314 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
JBrowse link
G Rad51 RAD51 recombinase decreases expression
multiple interactions
ISO selenocystine results in decreased expression of RAD51 protein
[Cisplatin co-treated with selenocystine] results in decreased expression of RAD51 protein; selenocystine inhibits the reaction [Cisplatin results in increased expression of RAD51 protein]
CTD PMID:39461470 NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
JBrowse link
G Slc3a1 solute carrier family 3 member 1 increases uptake ISO SLC3A1 protein results in increased uptake of selenocystine CTD PMID:18845132 NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
JBrowse link
G Sod1 superoxide dismutase 1 decreases expression ISO selenocystine results in decreased expression of SOD1 protein CTD PMID:35863474 NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
JBrowse link
G Sod2 superoxide dismutase 2 decreases expression ISO selenocystine results in decreased expression of SOD2 protein CTD PMID:35863474 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
JBrowse link
G Txnrd1 thioredoxin reductase 1 decreases response to substance
multiple interactions
increases expression
ISO TXNRD1 protein results in decreased susceptibility to selenocystine
NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of TXNRD1 mRNA]
selenocystine results in increased expression of TXNRD1 mRNA; selenocystine results in increased expression of TXNRD1 protein
CTD PMID:20920480 PMID:22807314 NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
JBrowse link
G Xpa XPA, DNA damage recognition and repair factor multiple interactions
decreases activity
ISO selenocystine inhibits the reaction [Zinc binds to XPA protein]
selenocystine results in decreased activity of XPA protein
CTD PMID:15265038 NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
JBrowse link
G Xrcc4 X-ray repair cross complementing 4 decreases expression
multiple interactions
ISO selenocystine results in decreased expression of XRCC4 protein
[Cisplatin co-treated with selenocystine] results in decreased expression of XRCC4 protein; Cisplatin promotes the reaction [selenocystine results in decreased expression of XRCC4 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of XRCC4 protein]
CTD PMID:39461470 NCBI chr 2:20,948,464...21,197,705
Ensembl chr 2:20,951,200...21,197,808
JBrowse link
G Xrcc5 X-ray repair cross complementing 5 decreases expression ISO selenocystine results in decreased expression of XRCC5 protein CTD PMID:39461470 NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
JBrowse link
G Xrcc6 X-ray repair cross complementing 6 multiple interactions
decreases expression
ISO selenocystine promotes the reaction [Cisplatin results in decreased expression of XRCC6 protein]
selenocystine results in decreased expression of XRCC6 protein
CTD PMID:39461470 NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19880
    chemical entity 19878
      atom 19878
        nonmetal atom 19800
          selenium atom 3261
            selenium molecular entity 3261
              diselenide 17
                selenocystine 17
                selenohomocystine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19880
    subatomic particle 19878
      composite particle 19878
        hadron 19878
          baryon 19878
            nucleon 19878
              atomic nucleus 19878
                atom 19878
                  main group element atom 19817
                    p-block element atom 19817
                      p-block molecular entity 19817
                        chalcogen molecular entity 19569
                          selenium molecular entity 3261
                            diselenide 17
                              selenocystine 17
                              selenohomocystine 0
paths to the root